Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Cook

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
JBMR Plus|April 20, 2026
Effects of cocoa extract supplementation on physical performance measures: results from the randomized controlled COcoa Supplement and Multivitamin Outcomes studySharon H Chou, Nancy Cook, Eunjung Kim, et al.
Clinical Trials (London, England)|February 25, 2016
The treatment of missing data in a large cardiovascular clinical outcomes studyRoderick J Little, Julia Wang, Xiang Sun, et al.
Journal of the American College of Cardiology|June 29, 2019
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSonia S Anand, John W Eikelboom, Leanne Dyal, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|October 30, 2020
Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarctionGopi Krishna Panicker, Dhiraj D Narula, Christine M Albert, et al.
European Journal of Heart Failure|June 5, 2015
Agents with vasodilator properties in acute heart failure: how to design successful trialsAlexandre Mebazaa, Dan Longrois, Marco Metra, et al.
Journal of the American College of Cardiology|March 16, 2018
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS TrialSonia S Anand, Francois Caron, John W Eikelboom, et al.
The New England Journal of Medicine|November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndromeJessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
Journal of the American College of Cardiology|September 21, 2019
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus AspirinJohn W Eikelboom, Jacqueline J Bosch, Stuart J Connolly, et al.
Annals of the New York Academy of Sciences|May 25, 2013
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditionsTroy C Sarich, Gary Peters, Scott D Berkowitz, et al.
Circulation|January 23, 2019
Stroke Outcomes in the COMPASS TrialMukul Sharma, Robert G Hart, Stuart J Connolly, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
JBMR Plus|April 20, 2026
Effects of cocoa extract supplementation on physical performance measures: results from the randomized controlled COcoa Supplement and Multivitamin Outcomes studySharon H Chou, Nancy Cook, Eunjung Kim, et al.
Clinical Trials (London, England)|February 25, 2016
The treatment of missing data in a large cardiovascular clinical outcomes studyRoderick J Little, Julia Wang, Xiang Sun, et al.
Journal of the American College of Cardiology|June 29, 2019
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSonia S Anand, John W Eikelboom, Leanne Dyal, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|October 30, 2020
Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarctionGopi Krishna Panicker, Dhiraj D Narula, Christine M Albert, et al.
European Journal of Heart Failure|June 5, 2015
Agents with vasodilator properties in acute heart failure: how to design successful trialsAlexandre Mebazaa, Dan Longrois, Marco Metra, et al.
Journal of the American College of Cardiology|March 16, 2018
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS TrialSonia S Anand, Francois Caron, John W Eikelboom, et al.
The New England Journal of Medicine|November 15, 2011
Rivaroxaban in patients with a recent acute coronary syndromeJessica L Mega, Eugene Braunwald, Stephen D Wiviott, et al.
Journal of the American College of Cardiology|September 21, 2019
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus AspirinJohn W Eikelboom, Jacqueline J Bosch, Stuart J Connolly, et al.
Annals of the New York Academy of Sciences|May 25, 2013
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditionsTroy C Sarich, Gary Peters, Scott D Berkowitz, et al.
Circulation|January 23, 2019
Stroke Outcomes in the COMPASS TrialMukul Sharma, Robert G Hart, Stuart J Connolly, et al.
Pageof 4